Indications and uses
Dries the oozing and weeping, and temporarily relieves pain and itching of poison ivy, poison oak, and poison sumac and other minor skin irritations.
Dries the oozing and weeping, and temporarily relieves pain and itching of poison ivy, poison oak, and poison sumac and other minor skin irritations.
Adults and children 2 yrs. of age and older. Shake well before using. cleanse the skin with soap and water. Let dry before each use. apply lotion to the affected area using cotton or soft cloth, not more than 3 to 4 times daily as needed for comfort. children unedr 2 yrs. of age. Consult a doctor before use.
Drug Facts
Pramoxine HCl 1%
External analgesic
Zinc Acetate 0.1%
Skin protectant
Dries the oozing and weeping, and temporarily relieves pain and itching of poison ivy, poison oak, and poison sumac and other minor skin irritations.
For External Use Only. Use only as directed. Avoid contact with eye and mucous membranes. ask a doctor before using on children under 2 years of age.
condition worsens. Symptoms last for more than 7 days or celar up and occur again whitin a few days.
In case of accidental ingestion, seek professional assistance or contact a Poison Control Center immediately.
Adults and children 2 yrs. of age and older. Shake well before using. cleanse the skin with soap and water. Let dry before each use. apply lotion to the affected area using cotton or soft cloth, not more than 3 to 4 times daily as needed for comfort.
children unedr 2 yrs. of age. Consult a doctor before use.
SD alcohol 38B 2.5%, Camphor, Diazolidinyl Urea, Fragrances, Glycerin, Hydroxypropyl Methylcellulose, Methylparaben, Polysorbate 80, Propylene Glycol, Propylparaben, and Purified Water.
Store at room temperature 15 - 30 (59-86F)
Distributed by: AmerisourceBergen
1300 Morris Drive, Chesterbrook, PA 19087
1-800-662-3435
www.goodneighborpharmacy.com
| Class | Version | Type | Effective |
|---|---|---|---|
| ZINC CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0087701400452 | GTIN-13: 0087701400452 EAN-13: 0087701400452 GTIN-12: 087701400452 UPC-A: 087701400452 GTIN storage (14 digits): 00087701400452 | GNPCaldy.jpg |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f47a510b-6679-4664-b2d6-47b5c4afe7cc | Product name | 4 | 20260217 |
| 030ce964-9b2d-45aa-b5d3-f78ce03ef61c | Product name | 2 | 20250515 |
| 0306390c-dd77-4363-afe0-63c58088b2a1 | Product name | 1 | 20220120 |
| 503ea967-4b9c-48cf-9e87-c7975295849d | Product name | 2 | 20220120 |
| 190f2a5b-bbc8-65c7-fcb0-97891307b917 | Product name | 1 | 20140508 |
| 58f3f9b7-3b9b-a9c1-1c9f-18ac777192b8 | Product name | 1 | 20140508 |
| a7051cba-790b-a699-81f8-dbbbdbd9b5ac | Product name | 1 | 20140508 |
| da108d9e-edc8-17a3-8c28-3251c6a8accc | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 24385-439-30 | 2022-07-29 | C162847 | 48780-1 | 9d75b9d0-c229-f424-e053-dadaa90a57ce | Caldyphen Clear |
| 24385-439-30 | 2020-03-18 | C162847 | 48780-1 | 9d75b9d0-c229-f424-e053-dadaa90a57ce | Caldyphen Clear |
| 24385-439-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-c229-f424-e053-dadaa90a57ce | Caldyphen Clear |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 24385-439-30 | Caldyphen Clear | 177 mL in 1 BOTTLE, PLASTIC | LOTION | 177 | 4 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 24385-439-30 | ML - Milliliter | 24385-439 | 91af2a34-0e06-412d-945e-e515b9815f8a | 1 | 2013-07-02 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| PRAMOXINE HYDROCHLORIDE | ACTIVE INGREDIENT | 88AYB867L5 | 1 | |
| ZINC ACETATE | ACTIVE INGREDIENT | FM5526K07A | 1 | |
| PRAMOXINE | ACTIVE MOIETY | 068X84E056 | 1 | |
| ZINC CATION | ACTIVE MOIETY | 13S1S8SF37 | 1 | |
| CAMPHOR (NATURAL) | INACTIVE INGREDIENT | N20HL7Q941 | 1 | |
| DIAZOLIDINYL UREA | INACTIVE INGREDIENT | H5RIZ3MPW4 | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | INACTIVE INGREDIENT | R75537T0T4 | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 1 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 1 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 24385-439 | 24385-439-30 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CAMPHOR (NATURAL) | N20HL7Q941 | IACT |
| DIAZOLIDINYL UREA | H5RIZ3MPW4 | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| HYPROMELLOSE, UNSPECIFIED | 3NXW29V3WO | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| POLYSORBATE 80 | 6OZP39ZG8H | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| WATER | 059QF0KO0R | IACT |
| PRAMOXINE HYDROCHLORIDE | 88AYB867L5 | ACTIB |
| ZINC ACETATE | FM5526K07A | ACTIM |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | TABLET, DELAYED RELEASE / ORAL | 103 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | TABLET, FILM COATED / ORAL | 264 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | GUM, CHEWING / BUCCAL | 336 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | CAPSULE / ORAL | 930 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | SYRUP / ORAL | 200 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | FILM, SOLUBLE / ORAL | 201 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | TABLET, EXTENDED RELEASE / ORAL | 670 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | CAPSULE, EXTENDED RELEASE / ORAL | 1508 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | SPRAY, METERED / NASAL | 1 mg/1ml | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | POWDER, FOR SUSPENSION / ORAL | 2940 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | TABLET / ORAL | 1200 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | SYRUP / ORAL | 200 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | FILM / SUBLINGUAL | 4.68 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | CAPSULE, DELAYED RELEASE / ORAL | 563 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | SUSPENSION, EXTENDED RELEASE / ORAL | 727 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | TABLET, FILM COATED / ORAL | 264 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | TABLET / ORAL | 1200 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | CAPSULE, DELAYED RELEASE / ORAL | 563 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | CAPSULE, EXTENDED RELEASE / ORAL | 1508 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | FILM / SUBLINGUAL | 4.68 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | TABLET, ORALLY DISINTEGRATING / ORAL | 25 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | LOTION / TOPICAL | 140 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | TABLET / BUCCAL | 5 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | SUSPENSION, EXTENDED RELEASE / ORAL | 727 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 107 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | SPRAY / NASAL | 1 mg/1ml | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | SUSPENSION / ORAL | 975 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | TABLET, ORALLY DISINTEGRATING / ORAL | 25 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | LOTION / TOPICAL | 3392 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | TABLET, FOR SUSPENSION / ORAL | 76 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| DIAZOLIDINYL UREA | DIAZOLIDINYL UREA | H5RIZ3MPW4 | LOTION / TOPICAL | 3 %w/w | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | FILM, SOLUBLE / ORAL | 201 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | LOTION / TOPICAL | 140 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | POWDER, FOR SUSPENSION / ORAL | 2940 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | LOTION / TOPICAL | 351 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | SPRAY / NASAL | 1 mg/1ml | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | SPRAY, METERED / NASAL | 1 mg/1ml | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | TABLET, COATED / ORAL | 24 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | POWDER / NASAL | NA | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | TABLET, CHEWABLE / ORAL | 120 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | TABLET, COATED / ORAL | 24 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 107 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | TABLET / BUCCAL | 5 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | LOTION / TOPICAL | 3392 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | CAPSULE / ORAL | 930 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | LOTION / TOPICAL | 351 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | SUSPENSION / ORAL | 975 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | POWDER / NASAL | NA | ||
| DIAZOLIDINYL UREA | DIAZOLIDINYL UREA | H5RIZ3MPW4 | LOTION / TOPICAL | 3 %w/w | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | TABLET, FOR SUSPENSION / ORAL | 76 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | TABLET, CHEWABLE / ORAL | 120 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | LOTION / TOPICAL | 15 %w/w | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | TABLET, DELAYED RELEASE / ORAL | 103 mg | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | TABLET, EXTENDED RELEASE / ORAL | 670 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | LOTION / TOPICAL | 15 %w/w | ||
| HYDROXYPROPYL METHYLCELLULOSE E5 [II] | HYPROMELLOSE 2910 (5 MPA.S) | R75537T0T4 | GUM, CHEWING / BUCCAL | 336 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Caldyphen Clear | PRAMOXINE HYDROCHLORIDE AND ZINC ACETATE | Amerisource Bergen | d8802e56-649e-4494-86ee-7ca8841cc28b | 2026-05-27 | Warnings | 24385-439-30 24385-439 24385043930 52d4acc7-7f67-f62a-e063-6394a90a245d d8802e56-649e-4494-86ee-7ca8841cc28b |
Adverse event summaries are temporarily unavailable. Other product information remains available.